サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1303167

マイクロ流体市場：材料、コンポーネント、用途、エンドユーザー別-2023～2030年の世界予測

Microfluidics Market by Material, Component, Application, End User - Cumulative Impact of COVID-19, Russia Ukraine Conflict, and High Inflation - Global Forecast 2023-2030
出版日: | 発行: 360iResearch | ページ情報: 英文 192 Pages | 納期: 即日から翌営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円
マイクロ流体市場：材料、コンポーネント、用途、エンドユーザー別-2023～2030年の世界予測
出版日: 2023年06月12日
発行: 360iResearch
ページ情報: 英文 192 Pages
納期: 即日から翌営業日
ご注意事項 :
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 図表
  • 目次
概要

マイクロ流体の世界市場は、2023年に255億3,000万米ドル、CAGR 25.26%で大きく成長し、2030年には1,243億1,000万米ドルという驚異的な規模に達すると予測されています。

FPNVポジショニング・マトリックス

FPNVポジショニングマトリックスは世界のマイクロ流体市場を評価するために不可欠です。事業戦略と製品満足度の主要指標を調査することで、ベンダーの包括的な評価を提供し、ユーザーは特定のニーズに基づいた情報をもとに意思決定を行うことができます。この高度な分析により、ベンダーは成功の度合いが異なる4つの象限に整理されます：フォアフロント（F）、パスファインダー（P）、ニッチ（N）、バイタル（V）です。

市場シェア分析

市場シェア分析では、特定の市場領域におけるベンダーの現状を洞察することができます。全体的な収益、顧客基盤、その他の主要指標に対するベンダーの貢献度を比較することで、企業が市場シェアを争う際に、自社の業績や直面している状況をより深く理解することができます。また、本分析では、調査した基準年において、特定のセクターがどの程度競合しているのか、蓄積、断片化の優位性、合併の特徴についても明らかにしています。

本レポートは、以下のポイントに関する洞察を提供します：

1.市場の浸透度：主要企業が提供する市場に関する包括的な情報を提供します。

2.市場の発展：有利な新興市場に関する詳細情報を提供し、市場の成熟セグメントにおける浸透度を分析します。

3.市場の多様化：新製品の上市、未開発地域、最近の開発、投資に関する詳細情報を提供します。

4.市場の動向：COVID-19、ロシア・ウクライナ紛争、高インフレの累積的な影響を包括的に理解することができます。

5.競合の評価と情報：主要企業の市場シェア、戦略、製品、認証、規制状況、特許状況、製造能力を網羅的に評価します。

6.製品開発およびイノベーション：将来技術、研究開発活動、画期的な製品開発に関する知的洞察を提供します。

本レポートは、以下のような質問にお答えします：

1.マイクロ流体の世界市場規模および予測は？

2.予測期間中、世界のマイクロ流体市場を形成するCOVID-19の阻害要因と影響は？

3.マイクロ流体の世界市場において予測期間中に投資すべき製品/セグメント/用途/分野は？

4.マイクロ流体の世界市場における競争戦略は？

5.マイクロ流体の世界市場における技術動向と規制の枠組みは？

6.マイクロ流体の世界市場における主要ベンダーの市場シェアは？

7.マイクロ流体の世界市場への参入には、どのような形態や戦略的な動きが適していると考えられるか？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

  • 市場力学
    • 促進要因
      • 慢性疾患の発生率の増加とポイントオブケア検査の需要の増加
      • マイクロ流体チップの小型化と分析所要時間の短縮別デバイスの可搬性の向上
      • マイクロ流体を使用したドラッグデリバリーの潜在的な応用例
    • 抑制要因
      • 複雑で時間のかかる規制当局の承認プロセス
    • 機会
      • Organ-on-a-Chipなどのマイクロ流体ベースの3D細胞培養システムの開発
      • 生物医学分析および診断のためのマイクロ流体コンポーネントの進歩
    • 課題
      • マイクロ流体と既存のワークフローの統合
  • 市場動向
  • COVID-19の累積的な影響
  • ロシア・ウクライナ紛争の累積的影響
  • 高インフレの累積的影響
  • ポーターのファイブフォース分析
  • バリューチェーンとクリティカルパス分析
  • 規制の枠組み
  • 顧客のカスタマイズ

第6章 マイクロ流体市場：材料別

  • イントロダクション
  • ガラスベース
  • ポリマーベース
  • シリコンベース

第7章 マイクロ流体市場：コンポーネント別

  • イントロダクション
  • マイクロニードル
  • マイクロポンプ
  • マイクロ流体チップ

第8章 マイクロ流体市場：用途別

  • イントロダクション
  • 体外診断
    • 臨床診断
    • ポイントオブケア検査
    • 獣医診断
  • 製薬およびライフサイエンスの研究
    • ラボ分析
      • キャピラリー電気泳動
      • 細胞ベースのアッセイ
      • ゲノム解析
      • プロテオーム解析
    • マイクロディスペンス
    • マイクロリアクション
  • 治療
    • ドラッグデリバリー
    • ウェアラブルデバイス

第9章 マイクロ流体市場：エンドユーザー別

  • イントロダクション
  • 学術研究機関
  • 病院と診断センター
  • 製薬およびバイオテクノロジー企業

第10章 南北アメリカのマイクロ流体市場

  • イントロダクション
  • アルゼンチン
  • ブラジル
  • カナダ
  • メキシコ
  • 米国

第11章 アジア太平洋地域のマイクロ流体市場

  • イントロダクション
  • オーストラリア
  • 中国
  • インド
  • インドネシア
  • 日本
  • マレーシア
  • フィリピン
  • シンガポール
  • 韓国
  • 台湾
  • タイ
  • ベトナム

第12章 欧州・中東・アフリカのマイクロ流体市場

  • イントロダクション
  • デンマーク
  • エジプト
  • フィンランド
  • フランス
  • ドイツ
  • イスラエル
  • イタリア
  • オランダ
  • ナイジェリア
  • ノルウェー
  • ポーランド
  • カタール
  • ロシア
  • サウジアラビア
  • 南アフリカ
  • スペイン
  • スウェーデン
  • スイス
  • トルコ
  • アラブ首長国連邦
  • 英国

第13章 競合情勢

  • FPNVポジショニングマトリクス
  • 市場シェア分析：主要企業別
  • 競合シナリオ分析：主要企業別

第14章 掲載企業一覧

第15章 付録

  • ディスカッションガイド
  • ライセンスと価格について
図表

LIST OF FIGURES

  • FIGURE 1. MICROFLUIDICS MARKET RESEARCH PROCESS
  • FIGURE 2. MICROFLUIDICS MARKET SIZE, 2022 VS 2030
  • FIGURE 3. MICROFLUIDICS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. MICROFLUIDICS MARKET SIZE, BY MATERIAL, 2022 VS 2030 (%)
  • FIGURE 5. MICROFLUIDICS MARKET SIZE, BY COMPONENT, 2022 VS 2030 (%)
  • FIGURE 6. MICROFLUIDICS MARKET SIZE, BY APPLICATION, 2022 VS 2030 (%)
  • FIGURE 7. MICROFLUIDICS MARKET SIZE, BY END USER, 2022 VS 2030 (%)
  • FIGURE 8. MICROFLUIDICS MARKET SIZE, BY REGION, 2022 VS 2030 (%)
  • FIGURE 9. MICROFLUIDICS MARKET DYNAMICS
  • FIGURE 10. MICROFLUIDICS MARKET SIZE, BY MATERIAL, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 11. MICROFLUIDICS MARKET SIZE, BY COMPONENT, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 12. MICROFLUIDICS MARKET SIZE, BY APPLICATION, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 13. MICROFLUIDICS MARKET SIZE, BY END USER, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 14. AMERICAS MICROFLUIDICS MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 15. UNITED STATES MICROFLUIDICS MARKET SIZE, BY STATE, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 16. ASIA-PACIFIC MICROFLUIDICS MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 17. EUROPE, MIDDLE EAST & AFRICA MICROFLUIDICS MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 18. MICROFLUIDICS MARKET, FPNV POSITIONING MATRIX, 2022
  • FIGURE 19. MICROFLUIDICS MARKET SHARE, BY KEY PLAYER, 2022

LIST OF TABLES

  • TABLE 1. MICROFLUIDICS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2022
  • TABLE 3. MICROFLUIDICS MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. MICROFLUIDICS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 5. MICROFLUIDICS MARKET SIZE, BY GLASS-BASED, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 6. MICROFLUIDICS MARKET SIZE, BY POLYMER-BASED, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 7. MICROFLUIDICS MARKET SIZE, BY SILICON-BASED, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 8. MICROFLUIDICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 9. MICROFLUIDICS MARKET SIZE, BY MICRO NEEDLE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. MICROFLUIDICS MARKET SIZE, BY MICRO PUMP, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. MICROFLUIDICS MARKET SIZE, BY MICROFLUIDIC CHIP, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. MICROFLUIDICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 13. MICROFLUIDICS MARKET SIZE, BY IN-VITRO DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 14. MICROFLUIDICS MARKET SIZE, BY IN-VITRO DIAGNOSTICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. MICROFLUIDICS MARKET SIZE, BY CLINICAL DIAGNOSTICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. MICROFLUIDICS MARKET SIZE, BY POINT-OF-CARE TESTING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. MICROFLUIDICS MARKET SIZE, BY VETERINARY DIAGNOSTICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. MICROFLUIDICS MARKET SIZE, BY PHARMACEUTICAL & LIFE SCIENCE RESEARCH, 2018-2030 (USD MILLION)
  • TABLE 19. MICROFLUIDICS MARKET SIZE, BY PHARMACEUTICAL & LIFE SCIENCE RESEARCH, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. MICROFLUIDICS MARKET SIZE, BY LAB ANALYTICS, 2018-2030 (USD MILLION)
  • TABLE 21. MICROFLUIDICS MARKET SIZE, BY LAB ANALYTICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. MICROFLUIDICS MARKET SIZE, BY CAPILLARY ELECTROPHORESIS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. MICROFLUIDICS MARKET SIZE, BY CELL-BASED ASSAYS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. MICROFLUIDICS MARKET SIZE, BY GENOMIC ANALYSIS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. MICROFLUIDICS MARKET SIZE, BY PROTEOMIC ANALYSIS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 26. MICROFLUIDICS MARKET SIZE, BY MICRODISPENSING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 27. MICROFLUIDICS MARKET SIZE, BY MICROREACTION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 28. MICROFLUIDICS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
  • TABLE 29. MICROFLUIDICS MARKET SIZE, BY THERAPEUTICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 30. MICROFLUIDICS MARKET SIZE, BY DRUG DELIVERY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 31. MICROFLUIDICS MARKET SIZE, BY WEARABLE DEVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 32. MICROFLUIDICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 33. MICROFLUIDICS MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 34. MICROFLUIDICS MARKET SIZE, BY HOSPITALS & DIAGNOSTIC CENTERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 35. MICROFLUIDICS MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 36. AMERICAS MICROFLUIDICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 37. AMERICAS MICROFLUIDICS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 38. AMERICAS MICROFLUIDICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 39. AMERICAS MICROFLUIDICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 40. AMERICAS MICROFLUIDICS MARKET SIZE, BY IN-VITRO DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 41. AMERICAS MICROFLUIDICS MARKET SIZE, BY PHARMACEUTICAL & LIFE SCIENCE RESEARCH, 2018-2030 (USD MILLION)
  • TABLE 42. AMERICAS MICROFLUIDICS MARKET SIZE, BY LAB ANALYTICS, 2018-2030 (USD MILLION)
  • TABLE 43. AMERICAS MICROFLUIDICS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
  • TABLE 44. AMERICAS MICROFLUIDICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 45. ARGENTINA MICROFLUIDICS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 46. ARGENTINA MICROFLUIDICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 47. ARGENTINA MICROFLUIDICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 48. ARGENTINA MICROFLUIDICS MARKET SIZE, BY IN-VITRO DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 49. ARGENTINA MICROFLUIDICS MARKET SIZE, BY PHARMACEUTICAL & LIFE SCIENCE RESEARCH, 2018-2030 (USD MILLION)
  • TABLE 50. ARGENTINA MICROFLUIDICS MARKET SIZE, BY LAB ANALYTICS, 2018-2030 (USD MILLION)
  • TABLE 51. ARGENTINA MICROFLUIDICS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
  • TABLE 52. ARGENTINA MICROFLUIDICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 53. BRAZIL MICROFLUIDICS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 54. BRAZIL MICROFLUIDICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 55. BRAZIL MICROFLUIDICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 56. BRAZIL MICROFLUIDICS MARKET SIZE, BY IN-VITRO DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 57. BRAZIL MICROFLUIDICS MARKET SIZE, BY PHARMACEUTICAL & LIFE SCIENCE RESEARCH, 2018-2030 (USD MILLION)
  • TABLE 58. BRAZIL MICROFLUIDICS MARKET SIZE, BY LAB ANALYTICS, 2018-2030 (USD MILLION)
  • TABLE 59. BRAZIL MICROFLUIDICS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
  • TABLE 60. BRAZIL MICROFLUIDICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 61. CANADA MICROFLUIDICS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 62. CANADA MICROFLUIDICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 63. CANADA MICROFLUIDICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 64. CANADA MICROFLUIDICS MARKET SIZE, BY IN-VITRO DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 65. CANADA MICROFLUIDICS MARKET SIZE, BY PHARMACEUTICAL & LIFE SCIENCE RESEARCH, 2018-2030 (USD MILLION)
  • TABLE 66. CANADA MICROFLUIDICS MARKET SIZE, BY LAB ANALYTICS, 2018-2030 (USD MILLION)
  • TABLE 67. CANADA MICROFLUIDICS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
  • TABLE 68. CANADA MICROFLUIDICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 69. MEXICO MICROFLUIDICS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 70. MEXICO MICROFLUIDICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 71. MEXICO MICROFLUIDICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 72. MEXICO MICROFLUIDICS MARKET SIZE, BY IN-VITRO DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 73. MEXICO MICROFLUIDICS MARKET SIZE, BY PHARMACEUTICAL & LIFE SCIENCE RESEARCH, 2018-2030 (USD MILLION)
  • TABLE 74. MEXICO MICROFLUIDICS MARKET SIZE, BY LAB ANALYTICS, 2018-2030 (USD MILLION)
  • TABLE 75. MEXICO MICROFLUIDICS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
  • TABLE 76. MEXICO MICROFLUIDICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 77. UNITED STATES MICROFLUIDICS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 78. UNITED STATES MICROFLUIDICS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 79. UNITED STATES MICROFLUIDICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 80. UNITED STATES MICROFLUIDICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 81. UNITED STATES MICROFLUIDICS MARKET SIZE, BY IN-VITRO DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 82. UNITED STATES MICROFLUIDICS MARKET SIZE, BY PHARMACEUTICAL & LIFE SCIENCE RESEARCH, 2018-2030 (USD MILLION)
  • TABLE 83. UNITED STATES MICROFLUIDICS MARKET SIZE, BY LAB ANALYTICS, 2018-2030 (USD MILLION)
  • TABLE 84. UNITED STATES MICROFLUIDICS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
  • TABLE 85. UNITED STATES MICROFLUIDICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 86. ASIA-PACIFIC MICROFLUIDICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 87. ASIA-PACIFIC MICROFLUIDICS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 88. ASIA-PACIFIC MICROFLUIDICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 89. ASIA-PACIFIC MICROFLUIDICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 90. ASIA-PACIFIC MICROFLUIDICS MARKET SIZE, BY IN-VITRO DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 91. ASIA-PACIFIC MICROFLUIDICS MARKET SIZE, BY PHARMACEUTICAL & LIFE SCIENCE RESEARCH, 2018-2030 (USD MILLION)
  • TABLE 92. ASIA-PACIFIC MICROFLUIDICS MARKET SIZE, BY LAB ANALYTICS, 2018-2030 (USD MILLION)
  • TABLE 93. ASIA-PACIFIC MICROFLUIDICS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
  • TABLE 94. ASIA-PACIFIC MICROFLUIDICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 95. AUSTRALIA MICROFLUIDICS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 96. AUSTRALIA MICROFLUIDICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 97. AUSTRALIA MICROFLUIDICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 98. AUSTRALIA MICROFLUIDICS MARKET SIZE, BY IN-VITRO DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 99. AUSTRALIA MICROFLUIDICS MARKET SIZE, BY PHARMACEUTICAL & LIFE SCIENCE RESEARCH, 2018-2030 (USD MILLION)
  • TABLE 100. AUSTRALIA MICROFLUIDICS MARKET SIZE, BY LAB ANALYTICS, 2018-2030 (USD MILLION)
  • TABLE 101. AUSTRALIA MICROFLUIDICS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
  • TABLE 102. AUSTRALIA MICROFLUIDICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 103. CHINA MICROFLUIDICS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 104. CHINA MICROFLUIDICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 105. CHINA MICROFLUIDICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 106. CHINA MICROFLUIDICS MARKET SIZE, BY IN-VITRO DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 107. CHINA MICROFLUIDICS MARKET SIZE, BY PHARMACEUTICAL & LIFE SCIENCE RESEARCH, 2018-2030 (USD MILLION)
  • TABLE 108. CHINA MICROFLUIDICS MARKET SIZE, BY LAB ANALYTICS, 2018-2030 (USD MILLION)
  • TABLE 109. CHINA MICROFLUIDICS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
  • TABLE 110. CHINA MICROFLUIDICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 111. INDIA MICROFLUIDICS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 112. INDIA MICROFLUIDICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 113. INDIA MICROFLUIDICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 114. INDIA MICROFLUIDICS MARKET SIZE, BY IN-VITRO DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 115. INDIA MICROFLUIDICS MARKET SIZE, BY PHARMACEUTICAL & LIFE SCIENCE RESEARCH, 2018-2030 (USD MILLION)
  • TABLE 116. INDIA MICROFLUIDICS MARKET SIZE, BY LAB ANALYTICS, 2018-2030 (USD MILLION)
  • TABLE 117. INDIA MICROFLUIDICS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
  • TABLE 118. INDIA MICROFLUIDICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 119. INDONESIA MICROFLUIDICS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 120. INDONESIA MICROFLUIDICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 121. INDONESIA MICROFLUIDICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 122. INDONESIA MICROFLUIDICS MARKET SIZE, BY IN-VITRO DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 123. INDONESIA MICROFLUIDICS MARKET SIZE, BY PHARMACEUTICAL & LIFE SCIENCE RESEARCH, 2018-2030 (USD MILLION)
  • TABLE 124. INDONESIA MICROFLUIDICS MARKET SIZE, BY LAB ANALYTICS, 2018-2030 (USD MILLION)
  • TABLE 125. INDONESIA MICROFLUIDICS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
  • TABLE 126. INDONESIA MICROFLUIDICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 127. JAPAN MICROFLUIDICS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 128. JAPAN MICROFLUIDICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 129. JAPAN MICROFLUIDICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 130. JAPAN MICROFLUIDICS MARKET SIZE, BY IN-VITRO DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 131. JAPAN MICROFLUIDICS MARKET SIZE, BY PHARMACEUTICAL & LIFE SCIENCE RESEARCH, 2018-2030 (USD MILLION)
  • TABLE 132. JAPAN MICROFLUIDICS MARKET SIZE, BY LAB ANALYTICS, 2018-2030 (USD MILLION)
  • TABLE 133. JAPAN MICROFLUIDICS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
  • TABLE 134. JAPAN MICROFLUIDICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 135. MALAYSIA MICROFLUIDICS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 136. MALAYSIA MICROFLUIDICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 137. MALAYSIA MICROFLUIDICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 138. MALAYSIA MICROFLUIDICS MARKET SIZE, BY IN-VITRO DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 139. MALAYSIA MICROFLUIDICS MARKET SIZE, BY PHARMACEUTICAL & LIFE SCIENCE RESEARCH, 2018-2030 (USD MILLION)
  • TABLE 140. MALAYSIA MICROFLUIDICS MARKET SIZE, BY LAB ANALYTICS, 2018-2030 (USD MILLION)
  • TABLE 141. MALAYSIA MICROFLUIDICS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
  • TABLE 142. MALAYSIA MICROFLUIDICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 143. PHILIPPINES MICROFLUIDICS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 144. PHILIPPINES MICROFLUIDICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 145. PHILIPPINES MICROFLUIDICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 146. PHILIPPINES MICROFLUIDICS MARKET SIZE, BY IN-VITRO DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 147. PHILIPPINES MICROFLUIDICS MARKET SIZE, BY PHARMACEUTICAL & LIFE SCIENCE RESEARCH, 2018-2030 (USD MILLION)
  • TABLE 148. PHILIPPINES MICROFLUIDICS MARKET SIZE, BY LAB ANALYTICS, 2018-2030 (USD MILLION)
  • TABLE 149. PHILIPPINES MICROFLUIDICS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
  • TABLE 150. PHILIPPINES MICROFLUIDICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 151. SINGAPORE MICROFLUIDICS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 152. SINGAPORE MICROFLUIDICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 153. SINGAPORE MICROFLUIDICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 154. SINGAPORE MICROFLUIDICS MARKET SIZE, BY IN-VITRO DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 155. SINGAPORE MICROFLUIDICS MARKET SIZE, BY PHARMACEUTICAL & LIFE SCIENCE RESEARCH, 2018-2030 (USD MILLION)
  • TABLE 156. SINGAPORE MICROFLUIDICS MARKET SIZE, BY LAB ANALYTICS, 2018-2030 (USD MILLION)
  • TABLE 157. SINGAPORE MICROFLUIDICS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
  • TABLE 158. SINGAPORE MICROFLUIDICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 159. SOUTH KOREA MICROFLUIDICS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 160. SOUTH KOREA MICROFLUIDICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 161. SOUTH KOREA MICROFLUIDICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 162. SOUTH KOREA MICROFLUIDICS MARKET SIZE, BY IN-VITRO DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 163. SOUTH KOREA MICROFLUIDICS MARKET SIZE, BY PHARMACEUTICAL & LIFE SCIENCE RESEARCH, 2018-2030 (USD MILLION)
  • TABLE 164. SOUTH KOREA MICROFLUIDICS MARKET SIZE, BY LAB ANALYTICS, 2018-2030 (USD MILLION)
  • TABLE 165. SOUTH KOREA MICROFLUIDICS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
  • TABLE 166. SOUTH KOREA MICROFLUIDICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 167. TAIWAN MICROFLUIDICS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 168. TAIWAN MICROFLUIDICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 169. TAIWAN MICROFLUIDICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 170. TAIWAN MICROFLUIDICS MARKET SIZE, BY IN-VITRO DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 171. TAIWAN MICROFLUIDICS MARKET SIZE, BY PHARMACEUTICAL & LIFE SCIENCE RESEARCH, 2018-2030 (USD MILLION)
  • TABLE 172. TAIWAN MICROFLUIDICS MARKET SIZE, BY LAB ANALYTICS, 2018-2030 (USD MILLION)
  • TABLE 173. TAIWAN MICROFLUIDICS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
  • TABLE 174. TAIWAN MICROFLUIDICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 175. THAILAND MICROFLUIDICS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 176. THAILAND MICROFLUIDICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 177. THAILAND MICROFLUIDICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 178. THAILAND MICROFLUIDICS MARKET SIZE, BY IN-VITRO DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 179. THAILAND MICROFLUIDICS MARKET SIZE, BY PHARMACEUTICAL & LIFE SCIENCE RESEARCH, 2018-2030 (USD MILLION)
  • TABLE 180. THAILAND MICROFLUIDICS MARKET SIZE, BY LAB ANALYTICS, 2018-2030 (USD MILLION)
  • TABLE 181. THAILAND MICROFLUIDICS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
  • TABLE 182. THAILAND MICROFLUIDICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 183. VIETNAM MICROFLUIDICS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 184. VIETNAM MICROFLUIDICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 185. VIETNAM MICROFLUIDICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 186. VIETNAM MICROFLUIDICS MARKET SIZE, BY IN-VITRO DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 187. VIETNAM MICROFLUIDICS MARKET SIZE, BY PHARMACEUTICAL & LIFE SCIENCE RESEARCH, 2018-2030 (USD MILLION)
  • TABLE 188. VIETNAM MICROFLUIDICS MARKET SIZE, BY LAB ANALYTICS, 2018-2030 (USD MILLION)
  • TABLE 189. VIETNAM MICROFLUIDICS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
  • TABLE 190. VIETNAM MICROFLUIDICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 191. EUROPE, MIDDLE EAST & AFRICA MICROFLUIDICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 192. EUROPE, MIDDLE EAST & AFRICA MICROFLUIDICS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 193. EUROPE, MIDDLE EAST & AFRICA MICROFLUIDICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 194. EUROPE, MIDDLE EAST & AFRICA MICROFLUIDICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 195. EUROPE, MIDDLE EAST & AFRICA MICROFLUIDICS MARKET SIZE, BY IN-VITRO DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 196. EUROPE, MIDDLE EAST & AFRICA MICROFLUIDICS MARKET SIZE, BY PHARMACEUTICAL & LIFE SCIENCE RESEARCH, 2018-2030 (USD MILLION)
  • TABLE 197. EUROPE, MIDDLE EAST & AFRICA MICROFLUIDICS MARKET SIZE, BY LAB ANALYTICS, 2018-2030 (USD MILLION)
  • TABLE 198. EUROPE, MIDDLE EAST & AFRICA MICROFLUIDICS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
  • TABLE 199. EUROPE, MIDDLE EAST & AFRICA MICROFLUIDICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 200. DENMARK MICROFLUIDICS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 201. DENMARK MICROFLUIDICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 202. DENMARK MICROFLUIDICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 203. DENMARK MICROFLUIDICS MARKET SIZE, BY IN-VITRO DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 204. DENMARK MICROFLUIDICS MARKET SIZE, BY PHARMACEUTICAL & LIFE SCIENCE RESEARCH, 2018-2030 (USD MILLION)
  • TABLE 205. DENMARK MICROFLUIDICS MARKET SIZE, BY LAB ANALYTICS, 2018-2030 (USD MILLION)
  • TABLE 206. DENMARK MICROFLUIDICS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
  • TABLE 207. DENMARK MICROFLUIDICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 208. EGYPT MICROFLUIDICS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 209. EGYPT MICROFLUIDICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 210. EGYPT MICROFLUIDICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 211. EGYPT MICROFLUIDICS MARKET SIZE, BY IN-VITRO DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 212. EGYPT MICROFLUIDICS MARKET SIZE, BY PHARMACEUTICAL & LIFE SCIENCE RESEARCH, 2018-2030 (USD MILLION)
  • TABLE 213. EGYPT MICROFLUIDICS MARKET SIZE, BY LAB ANALYTICS, 2018-2030 (USD MILLION)
  • TABLE 214. EGYPT MICROFLUIDICS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
  • TABLE 215. EGYPT MICROFLUIDICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 216. FINLAND MICROFLUIDICS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 217. FINLAND MICROFLUIDICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 218. FINLAND MICROFLUIDICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 219. FINLAND MICROFLUIDICS MARKET SIZE, BY IN-VITRO DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 220. FINLAND MICROFLUIDICS MARKET SIZE, BY PHARMACEUTICAL & LIFE SCIENCE RESEARCH, 2018-2030 (USD MILLION)
  • TABLE 221. FINLAND MICROFLUIDICS MARKET SIZE, BY LAB ANALYTICS, 2018-2030 (USD MILLION)
  • TABLE 222. FINLAND MICROFLUIDICS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
  • TABLE 223. FINLAND MICROFLUIDICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 224. FRANCE MICROFLUIDICS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 225. FRANCE MICROFLUIDICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 226. FRANCE MICROFLUIDICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 227. FRANCE MICROFLUIDICS MARKET SIZE, BY IN-VITRO DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 228. FRANCE MICROFLUIDICS MARKET SIZE, BY PHARMACEUTICAL & LIFE SCIENCE RESEARCH, 2018-2030 (USD MILLION)
  • TABLE 229. FRANCE MICROFLUIDICS MARKET SIZE, BY LAB ANALYTICS, 2018-2030 (USD MILLION)
  • TABLE 230. FRANCE MICROFLUIDICS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
  • TABLE 231. FRANCE MICROFLUIDICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 232. GERMANY MICROFLUIDICS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 233. GERMANY MICROFLUIDICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 234. GERMANY MICROFLUIDICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 235. GERMANY MICROFLUIDICS MARKET SIZE, BY IN-VITRO DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 236. GERMANY MICROFLUIDICS MARKET SIZE, BY PHARMACEUTICAL & LIFE SCIENCE RESEARCH, 2018-2030 (USD MILLION)
  • TABLE 237. GERMANY MICROFLUIDICS MARKET SIZE, BY LAB ANALYTICS, 2018-2030 (USD MILLION)
  • TABLE 238. GERMANY MICROFLUIDICS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
  • TABLE 239. GERMANY MICROFLUIDICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 240. ISRAEL MICROFLUIDICS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 241. ISRAEL MICROFLUIDICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 242. ISRAEL MICROFLUIDICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 243. ISRAEL MICROFLUIDICS MARKET SIZE, BY IN-VITRO DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 244. ISRAEL MICROFLUIDICS MARKET SIZE, BY PHARMACEUTICAL & LIFE SCIENCE RESEARCH, 2018-2030 (USD MILLION)
  • TABLE 245. ISRAEL MICROFLUIDICS MARKET SIZE, BY LAB ANALYTICS, 2018-2030 (USD MILLION)
  • TABLE 246. ISRAEL MICROFLUIDICS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
  • TABLE 247. ISRAEL MICROFLUIDICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 248. ITALY MICROFLUIDICS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 249. ITALY MICROFLUIDICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 250. ITALY MICROFLUIDICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 251. ITALY MICROFLUIDICS MARKET SIZE, BY IN-VITRO DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 252. ITALY MICROFLUIDICS MARKET SIZE, BY PHARMACEUTICAL & LIFE SCIENCE RESEARCH, 2018-2030 (USD MILLION)
  • TABLE 253. ITALY MICROFLUIDICS MARKET SIZE, BY LAB ANALYTICS, 2018-2030 (USD MILLION)
  • TABLE 254. ITALY MICROFLUIDICS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
  • TABLE 255. ITALY MICROFLUIDICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 256. NETHERLANDS MICROFLUIDICS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 257. NETHERLANDS MICROFLUIDICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 258. NETHERLANDS MICROFLUIDICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 259. NETHERLANDS MICROFLUIDICS MARKET SIZE, BY IN-VITRO DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 260. NETHERLANDS MICROFLUIDICS MARKET SIZE, BY PHARMACEUTICAL & LIFE SCIENCE RESEARCH, 2018-2030 (USD MILLION)
  • TABLE 261. NETHERLANDS MICROFLUIDICS MARKET SIZE, BY LAB ANALYTICS, 2018-2030 (USD MILLION)
  • TABLE 262. NETHERLANDS MICROFLUIDICS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
  • TABLE 263. NETHERLANDS MICROFLUIDICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 264. NIGERIA MICROFLUIDICS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 265. NIGERIA MICROFLUIDICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 266. NIGERIA MICROFLUIDICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 267. NIGERIA MICROFLUIDICS MARKET SIZE, BY IN-VITRO DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 268. NIGERIA MICROFLUIDICS MARKET SIZE, BY PHARMACEUTICAL & LIFE SCIENCE RESEARCH, 2018-2030 (USD MILLION)
  • TABLE 269. NIGERIA MICROFLUIDICS MARKET SIZE, BY LAB ANALYTICS, 2018-2030 (USD MILLION)
  • TABLE 270. NIGERIA MICROFLUIDICS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
  • TABLE 271. NIGERIA MICROFLUIDICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 272. NORWAY MICROFLUIDICS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 273. NORWAY MICROFLUIDICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 274. NORWAY MICROFLUIDICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 275. NORWAY MICROFLUIDICS MARKET SIZE, BY IN-VITRO DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 276. NORWAY MICROFLUIDICS MARKET SIZE, BY PHARMACEUTICAL & LIFE SCIENCE RESEARCH, 2018-2030 (USD MILLION)
  • TABLE 277. NORWAY MICROFLUIDICS MARKET SIZE, BY LAB ANALYTICS, 2018-2030 (USD MILLION)
  • TABLE 278. NORWAY MICROFLUIDICS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
  • TABLE 279. NORWAY MICROFLUIDICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 280. POLAND MICROFLUIDICS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 281. POLAND MICROFLUIDICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 282. POLAND MICROFLUIDICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 283. POLAND MICROFLUIDICS MARKET SIZE, BY IN-VITRO DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 284. POLAND MICROFLUIDICS MARKET SIZE, BY PHARMACEUTICAL & LIFE SCIENCE RESEARCH, 2018-2030 (USD MILLION)
  • TABLE 285. POLAND MICROFLUIDICS MARKET SIZE, BY LAB ANALYTICS, 2018-2030 (USD MILLION)
  • TABLE 286. POLAND MICROFLUIDICS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
  • TABLE 287. POLAND MICROFLUIDICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 288. QATAR MICROFLUIDICS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 289. QATAR MICROFLUIDICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 290. QATAR MICROFLUIDICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 291. QATAR MICROFLUIDICS MARKET SIZE, BY IN-VITRO DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 292. QATAR MICROFLUIDICS MARKET SIZE, BY PHARMACEUTICAL & LIFE SCIENCE RESEARCH, 2018-2030 (USD MILLION)
  • TABLE 293. QATAR MICROFLUIDICS MARKET SIZE, BY LAB ANALYTICS, 2018-2030 (USD MILLION)
  • TABLE 294. QATAR MICROFLUIDICS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
  • TABLE 295. QATAR MICROFLUIDICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 296. RUSSIA MICROFLUIDICS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 297. RUSSIA MICROFLUIDICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 298. RUSSIA MICROFLUIDICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 299. RUSSIA MICROFLUIDICS MARKET SIZE, BY IN-VITRO DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 300. RUSSIA MICROFLUIDICS MARKET SIZE, BY PHARMACEUTICAL & LIFE SCIENCE RESEARCH, 2018-2030 (USD MILLION)
  • TABLE 301. RUSSIA MICROFLUIDICS MARKET SIZE, BY LAB ANALYTICS, 2018-2030 (USD MILLION)
  • TABLE 302. RUSSIA MICROFLUIDICS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
  • TABLE 303. RUSSIA MICROFLUIDICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 304. SAUDI ARABIA MICROFLUIDICS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 305. SAUDI ARABIA MICROFLUIDICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 306. SAUDI ARABIA MICROFLUIDICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 307. SAUDI ARABIA MICROFLUIDICS MARKET SIZE, BY IN-VITRO DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 308. SAUDI ARABIA MICROFLUIDICS MARKET SIZE, BY PHARMACEUTICAL & LIFE SCIENCE RESEARCH, 2018-2030 (USD MILLION)
  • TABLE 309. SAUDI ARABIA MICROFLUIDICS MARKET SIZE, BY LAB ANALYTICS, 2018-2030 (USD MILLION)
  • TABLE 310. SAUDI ARABIA MICROFLUIDICS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
  • TABLE 311. SAUDI ARABIA MICROFLUIDICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 312. SOUTH AFRICA MICROFLUIDICS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 313. SOUTH AFRICA MICROFLUIDICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 314. SOUTH AFRICA MICROFLUIDICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 315. SOUTH AFRICA MICROFLUIDICS MARKET SIZE, BY IN-VITRO DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 316. SOUTH AFRICA MICROFLUIDICS MARKET SIZE, BY PHARMACEUTICAL & LIFE SCIENCE RESEARCH, 2018-2030 (USD MILLION)
  • TABLE 317. SOUTH AFRICA MICROFLUIDICS MARKET SIZE, BY LAB ANALYTICS, 2018-2030 (USD MILLION)
  • TABLE 318. SOUTH AFRICA MICROFLUIDICS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
  • TABLE 319. SOUTH AFRICA MICROFLUIDICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 320. SPAIN MICROFLUIDICS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 321. SPAIN MICROFLUIDICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 322. SPAIN MICROFLUIDICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 323. SPAIN MICROFLUIDICS MARKET SIZE, BY IN-VITRO DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 324. SPAIN MICROFLUIDICS MARKET SIZE, BY PHARMACEUTICAL & LIFE SCIENCE RESEARCH, 2018-2030 (USD MILLION)
  • TABLE 325. SPAIN MICROFLUIDICS MARKET SIZE, BY LAB ANALYTICS, 2018-2030 (USD MILLION)
  • TABLE 326. SPAIN MICROFLUIDICS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
  • TABLE 327. SPAIN MICROFLUIDICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 328. SWEDEN MICROFLUIDICS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 329. SWEDEN MICROFLUIDICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 330. SWEDEN MICROFLUIDICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 331. SWEDEN MICROFLUIDICS MARKET SIZE, BY IN-VITRO DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 332. SWEDEN MICROFLUIDICS MARKET SIZE, BY PHARMACEUTICAL & LIFE SCIENCE RESEARCH, 2018-2030 (USD MILLION)
  • TABLE 333. SWEDEN MICROFLUIDICS MARKET SIZE, BY LAB ANALYTICS, 2018-2030 (USD MILLION)
  • TABLE 334. SWEDEN MICROFLUIDICS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
  • TABLE 335. SWEDEN MICROFLUIDICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 336. SWITZERLAND MICROFLUIDICS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 337. SWITZERLAND MICROFLUIDICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 338. SWITZERLAND MICROFLUIDICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 339. SWITZERLAND MICROFLUIDICS MARKET SIZE, BY IN-VITRO DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 340. SWITZERLAND MICROFLUIDICS MARKET SIZE, BY PHARMACEUTICAL & LIFE SCIENCE RESEARCH, 2018-2030 (USD MILLION)
  • TABLE 341. SWITZERLAND MICROFLUIDICS MARKET SIZE, BY LAB ANALYTICS, 2018-2030 (USD MILLION)
  • TABLE 342. SWITZERLAND MICROFLUIDICS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
  • TABLE 343. SWITZERLAND MICROFLUIDICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 344. TURKEY MICROFLUIDICS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 345. TURKEY MICROFLUIDICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 346. TURKEY MICROFLUIDICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 347. TURKEY MICROFLUIDICS MARKET SIZE, BY IN-VITRO DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 348. TURKEY MICROFLUIDICS MARKET SIZE, BY PHARMACEUTICAL & LIFE SCIENCE RESEARCH, 2018-2030 (USD MILLION)
  • TABLE 349. TURKEY MICROFLUIDICS MARKET SIZE, BY LAB ANALYTICS, 2018-2030 (USD MILLION)
  • TABLE 350. TURKEY MICROFLUIDICS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
  • TABLE 351. TURKEY MICROFLUIDICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 352. UNITED ARAB EMIRATES MICROFLUIDICS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 353. UNITED ARAB EMIRATES MICROFLUIDICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 354. UNITED ARAB EMIRATES MICROFLUIDICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 355. UNITED ARAB EMIRATES MICROFLUIDICS MARKET SIZE, BY IN-VITRO DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 356. UNITED ARAB EMIRATES MICROFLUIDICS MARKET SIZE, BY PHARMACEUTICAL & LIFE SCIENCE RESEARCH, 2018-2030 (USD MILLION)
  • TABLE 357. UNITED ARAB EMIRATES MICROFLUIDICS MARKET SIZE, BY LAB ANALYTICS, 2018-2030 (USD MILLION)
  • TABLE 358. UNITED ARAB EMIRATES MICROFLUIDICS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
  • TABLE 359. UNITED ARAB EMIRATES MICROFLUIDICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 360. UNITED KINGDOM MICROFLUIDICS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 361. UNITED KINGDOM MICROFLUIDICS MARKET SIZE
目次
Product Code: MRR-036C5CF3A81B

The Global Microfluidics Market is forecasted to grow significantly, with a projected USD 25.53 billion in 2023 at a CAGR of 25.26% and expected to reach a staggering USD 124.31 billion by 2030.

The Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and High Inflation is expected to have significant long-term effects on the Global Microfluidics Market. The ongoing research considers the changes in consumer behavior, supply chain disruptions, and government interventions caused by the pandemic. Similarly, the report considers the ongoing political and economic uncertainty in Eastern Europe caused by the Russia-Ukraine Conflict and its potential implications for demand-supply balances, pressure on pricing variants, and import/export and trading. Additionally, the report addresses the impact of High Inflation on the global economy and details fiscal policies measuring and reducing its effects on demand, supply, cash flow, and currency exchange.

Market Segmentation & Coverage:

This research report categorizes the Global Microfluidics Market in order to forecast the revenues and analyze trends in each of following sub-markets:

Based on Material, market is studied across Glass-based, Polymer-based, and Silicon-based. The Glass-based commanded largest market share of 45.32% in 2022, followed by Polymer-based.

Based on Component, market is studied across Micro Needle, Micro Pump, and Microfluidic Chip. The Microfluidic Chip commanded largest market share of 53.96% in 2022, followed by Micro Pump.

Based on Application, market is studied across In-Vitro Diagnostics, Pharmaceutical & Life Science Research, and Therapeutics. The In-Vitro Diagnostics is further studied across Clinical Diagnostics, Point-Of-Care Testing, and Veterinary Diagnostics. The Pharmaceutical & Life Science Research is further studied across Lab Analytics, Microdispensing, and Microreaction. The Lab Analytics is further studied across Capillary Electrophoresis, Cell-based Assays, Genomic analysis, and Proteomic Analysis. The Therapeutics is further studied across Drug Delivery and Wearable Devices. The In-Vitro Diagnostics commanded largest market share of 43.57% in 2022, followed by Pharmaceutical & Life Science Research.

Based on End User, market is studied across Academic & Research Institutes, Hospitals & Diagnostic Centers, and Pharmaceutical & Biotechnology Companies. The Hospitals & Diagnostic Centers commanded largest market share of 42.77% in 2022, followed by Pharmaceutical & Biotechnology Companies.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom. The Europe, Middle East & Africa commanded largest market share of 37.60% in 2022, followed by Americas.

Market Statistics:

The report provides market sizing and forecasts across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF; multiple currency support helps organization leaders to make well-informed decisions. In this report, 2018 to 2021 are considered as historical years, 2022 is base year, 2023 is estimated year, and years from 2024 to 2030 are considered as forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix is essential for assessing the Global Microfluidics Market. It provides a comprehensive evaluation of vendors by examining key metrics within Business Strategy and Product Satisfaction, allowing users to make informed decisions based on their specific needs. This advanced analysis then organizes these vendors into four distinct quadrants, which represent varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital(V).

Market Share Analysis:

The Market Share Analysis offers an insightful look at the current state of vendors in a particular market space. By comparing vendor contributions to overall revenue, customer base, and other key metrics, we can give companies a greater understanding of their performance and what they are up against when competing for market share. The analysis also sheds light on just how competitive any given sector is about accumulation, fragmentation dominance, and amalgamation traits over the base year period studied.

The report provides insights on the following pointers:

1. Market Penetration: Provides comprehensive information on the market offered by the key players

2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes penetration across mature segments of the markets

3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments

4. Market Trends: Provides comprehensive understanding of the Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and the High Inflation

5. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players

6. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

1. What is the market size and forecast of the Global Microfluidics Market?

2. What are the inhibiting factors and impact of COVID-19 shaping the Global Microfluidics Market during the forecast period?

3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Microfluidics Market?

4. What is the competitive strategic window for opportunities in the Global Microfluidics Market?

5. What are the technology trends and regulatory frameworks in the Global Microfluidics Market?

6. What is the market share of the leading vendors in the Global Microfluidics Market?

7. What modes and strategic moves are considered suitable for entering the Global Microfluidics Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Limitations
  • 1.7. Assumptions
  • 1.8. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

  • 4.1. Introduction
  • 4.2. Microfluidics Market, by Material, 2022 vs 2030
  • 4.3. Microfluidics Market, by Component, 2022 vs 2030
  • 4.4. Microfluidics Market, by Application, 2022 vs 2030
  • 4.5. Microfluidics Market, by End User, 2022 vs 2030
  • 4.6. Microfluidics Market, by Region, 2022 vs 2030

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Growing Incidence of Chronic Diseases and Increasing Demand for Point-Of-Care Testing
      • 5.1.1.2. Improved Portability of Devices through Microfluidic Chip Miniaturization and Faster Turn-Around Time for Analysis
      • 5.1.1.3. Potential Applications of Drug Delivery using Microfluidics
    • 5.1.2. Restraints
      • 5.1.2.1. Complicated and Time-Consuming Regulatory Approval Process
    • 5.1.3. Opportunities
      • 5.1.3.1. Development of Microfluidic-Based 3D Cell Culture Systems such as Organ-on-a-Chip
      • 5.1.3.2. Advances in Microfluidic Components for Biomedical Analysis and Diagnostics
    • 5.1.4. Challenges
      • 5.1.4.1. Integration of Microfluidics with Existing Workflows
  • 5.2. Market Trends
  • 5.3. Cumulative Impact of COVID-19
  • 5.4. Cumulative Impact of Russia-Ukraine Conflict
  • 5.5. Cumulative Impact of High Inflation
  • 5.6. Porter's Five Forces Analysis
    • 5.6.1. Threat of New Entrants
    • 5.6.2. Threat of Substitutes
    • 5.6.3. Bargaining Power of Customers
    • 5.6.4. Bargaining Power of Suppliers
    • 5.6.5. Industry Rivalry
  • 5.7. Value Chain & Critical Path Analysis
  • 5.8. Regulatory Framework
  • 5.9. Client Customization

6. Microfluidics Market, by Material

  • 6.1. Introduction
  • 6.2. Glass-based
  • 6.3. Polymer-based
  • 6.4. Silicon-based

7. Microfluidics Market, by Component

  • 7.1. Introduction
  • 7.2. Micro Needle
  • 7.3. Micro Pump
  • 7.4. Microfluidic Chip

8. Microfluidics Market, by Application

  • 8.1. Introduction
  • 8.2. In-Vitro Diagnostics
    • 8.2.1. Clinical Diagnostics
    • 8.2.2. Point-Of-Care Testing
    • 8.2.3. Veterinary Diagnostics
  • 8.3. Pharmaceutical & Life Science Research
    • 8.3.1. Lab Analytics
      • 8.3.1.1. Capillary Electrophoresis
      • 8.3.1.2. Cell-based Assays
      • 8.3.1.3. Genomic analysis
      • 8.3.1.4. Proteomic Analysis
    • 8.3.2. Microdispensing
    • 8.3.3. Microreaction
  • 8.4. Therapeutics
    • 8.4.1. Drug Delivery
    • 8.4.2. Wearable Devices

9. Microfluidics Market, by End User

  • 9.1. Introduction
  • 9.2. Academic & Research Institutes
  • 9.3. Hospitals & Diagnostic Centers
  • 9.4. Pharmaceutical & Biotechnology Companies

10. Americas Microfluidics Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific Microfluidics Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa Microfluidics Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. FPNV Positioning Matrix
  • 13.2. Market Share Analysis, By Key Player
  • 13.3. Competitive Scenario Analysis, By Key Player

14. List of Company Mentioned

15. Appendix

  • 15.1. Discussion Guide
  • 15.2. License & Pricing